CN105664063A - Traditional Chinese medicine compound for improving thyroid carcinoma postoperative symptoms (syndrome of Qi stagnation and blood stasis) - Google Patents
Traditional Chinese medicine compound for improving thyroid carcinoma postoperative symptoms (syndrome of Qi stagnation and blood stasis) Download PDFInfo
- Publication number
- CN105664063A CN105664063A CN201610181052.2A CN201610181052A CN105664063A CN 105664063 A CN105664063 A CN 105664063A CN 201610181052 A CN201610181052 A CN 201610181052A CN 105664063 A CN105664063 A CN 105664063A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- radix
- chinese medicine
- stagnation
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to medicines, in particular to a traditional Chinese medicine compound for improving thyroid carcinoma postoperative symptoms (syndrome of Qi stagnation and blood stasis). Aiming at defects of existing western medicine techniques for treating thyroid carcinomas, the technical scheme includes that the traditional Chinese medicine compound for improving the thyroid carcinoma postoperative symptoms (syndrome of Qi stagnation and blood stasis) is composed of Radix Bupleuri, Pericarpium Citri Reticulatae Viride, Rhizoma Ligustici Wallichii, Rhizoma Cyperi, Spica Prunellae, Radix Curcumae, Bulbus Fritillariae Cirrhosae, Radix Ranunculi Ternati, Rhizoma Dioscoreae Nipponicae, Herba Hedyotidis Diffusae, Pseudobulbus Cremastrae seu Pleiones, Nidus Vespae, Rhizoma Sparganii, Rhizoma Curcumae, Radix et Folium Euonymi, Herba Salviae Chinesnsis, Radix Rhapontici, Concha Arcae, Aspongopus chinensis Dallas, Scorpio, Scolopendra, Lumbricus, Bombyx Batryticatus, Squama Manis and Carapax Trionycis. The traditional Chinese medicine compound has the advantages that postoperative rehabilitation can be accelerated, patients' life quality is improved, and relapse and metastasis of the thyroid carcinomas are prevented and retarded.
Description
Technical field
The present invention relates to medicine, particularly one improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (syndrome of qi stagnation and blood stasis).
Background technology
Thyroid carcinoma is incidence malignant tumor more typically, accounts for l%~2% of whole body malignant tumor, common with women, it is seen that in any age bracket. The sickness rate of current thyroid carcinoma is in the notable trend risen year by year. Thyroid carcinoma is divided into the polytypes such as papillary adenocarcinoma, filter blocking cancer, undifferentiated carcinoma, medullary carcinoma. Wherein papillary carcinoma clinic is the most common, accounts for the 50%~70% of thyroid carcinoma. The Therapeutic Method of thyroid carcinoma has operative treatment, radiotherapy, chemotherapy, endocrine therapy and Chinese medicine etc. At present " suppression of operation+iodine 131 treatment+thyroxin " be acknowledged as the best comprehensive therapeutic plan of papillary carcinoma, it is possible to decrease recurrence or transfer incidence rate. Owing to papillary carcinoma belongs to low-grade malignant tumor, patient usually can ignore postoperative rehabilitation, and operation can only excise visible carcinoma, but can not eliminate the damage that human body is caused by carcinoma, and papillary carcinoma is postoperative higher in former operative site relapse rate.
Therefore the rehabilitation that papillary carcinoma is postoperative should cause the attention of height. Chinese medical discrimination thinks that L thyroxine tab is because operation wound, visual area expose for a long time, anaesthetize the combined causes such as impact, tracheal intubation loss, operation position, postoperative long term positional, the treatment of postoperative iodine 131, hypothyroidism, causes patient to occur attacking outside wind heat, the various situations such as venation is impaired, qi depression to blood stasis, phlegm and blood stasis, wasting QI-blood body fluid, deficiency of both YIN and YANG.
Increasing evidence shows at present, and postoperative Chinese medicine can improve the untoward reaction that operation itself brings; Improve immunity, accelerate patient postoperative rehabilitation; Alleviate the untoward reaction of oral thyroid element sheet; The softening postoperative cervical region projection cicatrix of thyroid carcinoma; Alleviate chemotherapy side effect; Suppress Elityran, reduce Serum Thyroglobulin, it is prevented that with recurrence and the transfer etc. that delay thyroid carcinoma.
Postoperative pathogenesis many genus deficiency in origin and excess in superficiality, deficiency in origin is based on deficiency of qi and yin, and mark is real in the stagnation of QI, expectorant knot, blood stasis, liver-fire, ecchymosis, the two simulataneous insufficiency and excessive, reciprocal causation, common pathogenetic. Visible wind heat violates the pattern of syndrome such as table, stagnation of QI stagnation of phlegm, qi depression to blood stasis, high liver fire, deficiency of both QI and YIN, deficiency of qi and blood, deficiency of both YIN and YANG clinically. Take the remedy measures such as wind and heat dispersing, activating QI to eliminate phlegm, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, purging liver-fire, Replenishing QI and nourishing YIN, benefiting qi and nourishing blood, nourishing YIN and invigorating YANG accordingly.
Syndrome of qi stagnation and blood stasis is how postoperative in thyroid carcinoma or engenders after the clear first treatment of radioiodine, and mostly being women, clinical manifestation is for feeling depressed, irritability is easily cried, and fullness and distention in the chest and hypochondrium is uncomfortable, dizzy, in throat, foreign body sensation is obvious, can not swallow, not out, the vexed belch of gastral cavity, anorexia, operation on neck tract pain, cicatrix is obvious, menoxenia, shifts to an earlier date or postpones, white and thin fur is greasy, stringy pulse.
Summary of the invention
Defect for above-mentioned existing western medical treatment technology, the purpose of the present invention is exactly the dialectical theory from Chinese medicine, one is provided to improve the Chinese medicine of thyroid carcinoma postsurgery symptoms (syndrome of qi stagnation and blood stasis), the postoperative various clinical symptom of thyroid carcinoma can be effectively improved, accelerate postoperative rehabilitation, improve patients ' life quality, it is prevented that with the recurrence and the transfer that delay thyroid carcinoma. Solve to lack specificity therapeutic method, the problem causing patients ' life quality difference, thyroid carcinoma recurrence and transfer.
The technical scheme that this invention address that is: one improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (syndrome of qi stagnation and blood stasis), this compound recipe is by weighing scale: Radix Bupleuri 8-15g, Pericarpium Citri Reticulatae Viride 10-20g, Rhizoma Chuanxiong 15-25g, Rhizoma Cyperi 15-25g, Spica Prunellae 20-30g, Radix Curcumae 15-25g, Bulbus Fritillariae Uninbracteatae 10-20g, Radix Ranunculi Ternati 20-30g, Rhizoma Dioscoreae Nipponicae 15-25g, Herba Hedyotidis Diffusae 20-30g, Pseudobulbus Cremastrae Seu Pleiones 20-30g, Nidus Vespae 20-30g, Rhizoma Sparganii 10-20g, Rhizoma Curcumae 10-20g, winged euonymus 20-30g, Herba Salviae Chinensis 20-30g, Radix Rhapontici 15-25g, Concha Arcae 15-25g, CATHARSIUS 20-30g, Scorpio 10-15g, Scolopendra 10-15g, Pheretima 10-15g, Bombyx Batryticatus 10-15g, Squama Manis 8-15g, Carapax Trionycis 10-20g makes,
Its preparation method is:
Wherein, being mixed by above-mentioned Chinese medicine, put in container, add 1000ml water soaking half an hour, intense fire decocts to boiling, using slow fire boiling instead 30 minutes, filter, obtain filtrate, filtering residue adds 800ml water and decocts once again, filter, obtain filtrate, twice filtrate mixing is concentrated into 200-300ml, to obtain final product.
The pure traditional Chinese medicine of the present invention, there is liver-smoothing, qi-regulating, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving effect, many clinical symptoms of thyroid carcinoma postoperative (syndrome of qi stagnation and blood stasis) can be effectively improved, drug safety, accelerates patient postoperative rehabilitation, improves patients ' life quality, prevent and delay recurrence and the transfer of thyroid carcinoma, be the innovation on thyroid carcinoma postoperative rehabilitation medicine. The Chinese medicine that the present invention relates to, to improving, thyroid carcinoma postsurgery symptoms (syndrome of qi stagnation and blood stasis) effect is obvious, it is possible to accelerate postoperative rehabilitation, improves patients ' life quality, it is prevented that with the recurrence and the transfer that delay thyroid carcinoma.
Detailed description of the invention
Below in conjunction with embodiment, present disclosure is described in further detail:
Embodiment 1
One improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (syndrome of qi stagnation and blood stasis), and this compound recipe is by weighing scale: Radix Bupleuri 8g, Pericarpium Citri Reticulatae Viride 10g, Rhizoma Chuanxiong 15g, Rhizoma Cyperi 15g, Spica Prunellae 20g, Radix Curcumae 15g, Bulbus Fritillariae Uninbracteatae 10g, Radix Ranunculi Ternati 20g, Rhizoma Dioscoreae Nipponicae 15g, Herba Hedyotidis Diffusae 20g, Pseudobulbus Cremastrae Seu Pleiones 20g, Nidus Vespae 20g, Rhizoma Sparganii 10g, Rhizoma Curcumae 10g, winged euonymus 20g, Herba Salviae Chinensis 20g, Radix Rhapontici 15g, Concha Arcae 15g, CATHARSIUS 20g, Scorpio 10g, Scolopendra 10g, Pheretima 10g, Bombyx Batryticatus 10g, Squama Manis 8g, Carapax Trionycis 10g makes
Its preparation method is:
Being mixed by above-mentioned Chinese medicine, put in container, add 1000ml water soaking half an hour, intense fire decocts to boiling, using slow fire boiling instead 30 minutes, filter, obtain filtrate, filtering residue adds 800ml water and decocts once again, filter, obtain filtrate, twice filtrate mixing is concentrated into 200ml, to obtain final product.
Embodiment 2
One improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (syndrome of qi stagnation and blood stasis), and this compound recipe is by weighing scale: Radix Bupleuri 10g, Pericarpium Citri Reticulatae Viride 15g, Rhizoma Chuanxiong 20g, Rhizoma Cyperi 20g, Spica Prunellae 25g, Radix Curcumae 20g, Bulbus Fritillariae Uninbracteatae 15g, Radix Ranunculi Ternati 25g, Rhizoma Dioscoreae Nipponicae 20g, Herba Hedyotidis Diffusae 25g, Pseudobulbus Cremastrae Seu Pleiones 25g, Nidus Vespae 25g, Rhizoma Sparganii 15g, Rhizoma Curcumae 15g, winged euonymus 25g, Herba Salviae Chinensis 25g, Radix Rhapontici 20g, Concha Arcae 20g, CATHARSIUS 25g, Scorpio 12g, Scolopendra 12g, Pheretima 12g, Bombyx Batryticatus 12g, Squama Manis 10g, Carapax Trionycis 15g makes
Its preparation method is:
Being mixed by above-mentioned Chinese medicine, put in container, add 1000ml water soaking half an hour, intense fire decocts to boiling, using slow fire boiling instead 30 minutes, filter, obtain filtrate, filtering residue adds 800ml water and decocts once again, filter, obtain filtrate, twice filtrate mixing is concentrated into 250ml, to obtain final product.
Embodiment 3
One improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (syndrome of qi stagnation and blood stasis), and this compound recipe is by weighing scale: Radix Bupleuri 15g, Pericarpium Citri Reticulatae Viride 20g, Rhizoma Chuanxiong 25g, Rhizoma Cyperi 25g, Spica Prunellae 30g, Radix Curcumae 25g, Bulbus Fritillariae Uninbracteatae 20g, Radix Ranunculi Ternati 30g, Rhizoma Dioscoreae Nipponicae 25g, Herba Hedyotidis Diffusae 30g, Pseudobulbus Cremastrae Seu Pleiones 30g, Nidus Vespae 30g, Rhizoma Sparganii 20g, Rhizoma Curcumae 20g, winged euonymus 30g, Herba Salviae Chinensis 30g, Radix Rhapontici 25g, Concha Arcae 25g, CATHARSIUS 30g, Scorpio 15g, Scolopendra 15g, Pheretima 15g, Bombyx Batryticatus 15g, Squama Manis 15g, Carapax Trionycis 20g makes
Its preparation method is:
Being mixed by above-mentioned Chinese medicine, put in container, add 1000ml water soaking half an hour, intense fire decocts to boiling, using slow fire boiling instead 30 minutes, filter, obtain filtrate, filtering residue adds 800ml water and decocts once again, filter, obtain filtrate, twice filtrate mixing is concentrated into 300ml, to obtain final product.
In said components, wherein:
Radix Bupleuri:
Induce sweat and bring down a fever, dispersing the stagnated live-QI to relieve the stagnation of QI, rise and lift yang-energy; Generate heat for exterior syndrome, Shaoyang disease; Stagnation of QI due to depression of the liver; Collapse of QI, internal organs prolapse.
Pericarpium Citri Reticulatae Viride:
Soothing the liver dispelling the stagnated QI, removing food stagnancyization is stagnant; For Liver depression and Qi stagnation; Stagnation of QI epigastric pain; Abdominal pain due to retention of food; Chronic malaria mass in the abdomen.
Rhizoma Chuanxiong:
Blood-activating and qi-promoting, wind-expelling pain-stopping; For stagnation of QI and blood pain card; Headache, rheumatic arthralgia.
Rhizoma Cyperi:
Dispersing the stagnated live-QI to relieve the stagnation of QI, menstruction regulating and pain relieving, regulate the flow of vital energy in tune; For stagnation of QI due to depression of the liver hypochondriac pain, stomachache; Menoxenia, dysmenorrhea, distending pain of the breast; Abdominal pain due to stagnation of QI.
Spica Prunellae:
Clearing away heat-fire, improving eyesight, mass dissipating and swelling eliminating; For conjunctival congestion and swelling pain, dizziness of having a headache, order pearl nyctalgia; Scrofula, goiter; Acute mastitis toxic swelling.
Radix Curcumae:
Promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, clear away heart-fire removing heat from blood, promoting the function of the gallbladder to alleviate jaundice; For qi depression to blood stasis pain card; Calentura coma, epilepsy unconsciousness due to blockage of phlegm; Spit blood, epistaxis, vicarious menstruation, hematuria, stranguria with blood; Dampness-heat in the liver and gallbladder jaundice, cholelithiasis.
Bulbus Fritillariae Uninbracteatae:
Removing heat-phlegm, mass dissipating and swelling eliminating; For cough due to consumptive disease, lung-heat type cough; Scrofula, acute mastitis, lung abscess.
Radix Ranunculi Ternati:
Dissipating phlegm and resolving masses, removing toxic substances and promoting subsidence of swelling; For scrofula sucutaneous nodule; Furuncle, snake bite and insect sting.
Rhizoma Dioscoreae Nipponicae:
Wind-damp dispelling, promoting blood circulation to remove obstruction in the collateral, removing heat from the lung and dissipating phlegm; For rheumatism arthromyodynia; Expectorant dyspnea of heat type is coughed.
Herba Hedyotidis Diffusae:
Heat-clearing and toxic substances removing, dampness removing is treating stranguria; For carbuncle sore tumefacting virus, laryngopharynx swelling and pain, venom; The puckery pain of pyretic stranguria.
Pseudobulbus Cremastrae Seu Pleiones:
Heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation; For carbuncle furunculosis, scrofula sucutaneous nodule; Abdominal mass mass in the abdomen.
Nidus Vespae:
Merit poisoning worm, wind-expelling pain-stopping; For sore swollen toxin, acute mastitis, scrofula, stubborn dermatitis pruritus, cancerous protuberance; Rheumatic arthralgia, toothache, rubella pruritus.
Rhizoma Sparganii:
Removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving; Gather for abdominal mass, amenorrhea, trusted subordinate's stasis of blood pain; Food stagnation abdominal distention.
Rhizoma Curcumae:
Removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving; Gather for abdominal mass, amenorrhea, trusted subordinate's stasis of blood pain; Food stagnation abdominal distention.
Winged euonymus:
Removing blood stasis, stimulates the menstrual flow, parasite killing; For amenorrhea, abdominal mass, puerperal the stagnant stomachache of the stasis of blood, abdominal pain due to worm stagnation.
Herba Salviae Chinensis:
Heat-clearing and toxic substances removing, blood circulation promoting regulates qi pain relieving; Swell for acute, chronic hepatitis, gastral cavity side of body distending pain, damp-heat vaginal discharge, mastitis, furuncle.
Radix Rhapontici:
Heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, stimulating milk secretion of stimulating the menstrual flow, relaxing muscles and tendons is promoted blood circulation; Swell and ache for acute mastitis, scrofula sore; Agalactia; Arthralgia chiefly caused by damp pathogen contracture.
Concha Arcae:
Eliminating phlegm and softening indurated mass, blood stasis-eliminating and stagnation-dissipating, relieving gastric hyperacidity to alleviate stomachache; For scrofula, goiter, abdominal mass mass in the abdomen, forge with for incoordination between the liver and stomach, stomachache acid regurgitation.
CATHARSIUS:
Broken knot, logical two just, epilepsy of calming the frightened, and removing toxic substances and promoting tissue regeneration dissipates swollen hemostasis;For solidity constipation; Rheumatic arthralgia, cancerous protuberance heavily fortified point block, red from dysentery.
Scorpio:
Endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain; Twitch for spasm; Sore swollen toxin, scrofula tuberculosis; Rheumatoid arthritis stubborn; Intractable migraine and general headache.
Scolopendra:
Endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain; Twitch for spasm; Sore swollen toxin, scrofula tuberculosis; Rheumatoid arthritis stubborn; Intractable headache.
Pheretima:
Clearing heat for calming endogenous wind, dredging collateral, relieving asthma, diuresis; For high hot infantile convulsion, demented; Blood stagnancy due to deficiency of QI, hemiplegia; Arthromyodynia; Lung-heat asthma; Dysuria, urine retention is obstructed.
Squama Manis:
Invigorate blood circulation and disappear, stimulating milk secretion of stimulating the menstrual flow, detumescence and apocenosis; For abdominal mass, amenorrhea; Rheumatic arthralgia, paralysis due to windstroke; Lack of lactation after delivery; Carbuncle sore tumefacting virus, scrofula.
Bombyx Batryticatus:
Breath phoenix relieving convulsion, wind-expelling pain-stopping, dissipating phlegm and resolving masses; Twitch for infantile convulsion; Wind apoplex involving the channels and collaterals, facial hemiparalysis; Headache due to pathogenic wind-heat, conjunctival congestion, pharyngalgia, rubella pruritus; Sucutaneous nodule, scrofula.
Carapax Trionycis:
Nourishing YIN for suppressing the hyperactive YANG, brings down a fever except steaming, hard masses softening and resolving; For syndrome of yin deficiency of liver and kidney; Abdominal mass is gathered.
Above-mentioned component science, reasonable compatibility, support mutually, has effect of liver-smoothing, qi-regulating, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, is effective to treatment thyroid carcinoma, good effect, drug safety, and obtains through clinical data and fully prove,
Relevant clinical data is as follows:
(1), the inclusion criteria of thyroid cancer patients:
All cases is all made a definite diagnosis through preoperative B ultrasonic, thyroid radioisotope scanning or needle biopsy, and selects for thyroid carcinoma through verified by postoperative pathology diagnosis. Accompany or without abnormal thyroid function.
(2), the exclusion standard of thyroid cancer patients:
Gestation, women breast-feeding their children, abnormal liver function person; It is associated with the severe primary diseases such as cardiovascular, liver, kidney and hemopoietic system, psychotic; Accept other Chinese medicines, glucocorticoid and other immunosuppressant treatment person; Other drug clinical trial person is participated in nearly March.
(3), efficacy assessment standard:
Comprehensive therapeutic effect criterion: computing formula: (treatment foreset divide and rule treatment after integration)/treatment before integration, be expressed as a percentage. Recovery from illness: symptom and sign disappears substantially, and integration is more than or equal to 95%; Effective: symptom and sign is obviously improved, integration integration is more than or equal to 75%; Effective: symptom and sign take a favorable turn, integration is more than or equal to 50%; Invalid: symptom and sign is not improved, even increase the weight of, integration is less than 50%.
(4), therapeutic scheme:
To the patient that diagnosis is thyroid carcinoma, treating with the Chinese medicine of the present invention, when taking, sooner or later respectively once, each 100-150ml, two hours after meal cool clothes, 7 days are a course for the treatment of, add up curative effect after 4 courses for the treatment of.
(5), statistical procedures:
Selected thyroid cancer patients totally 52 example, wherein male 21 examples, female 31 example, the age is (52.8 ± 12.5) year. By above-mentioned (four) therapeutic scheme, the Chinese medicine that the oral present invention provides, add up after 6 courses for the treatment of, effective 21 examples of clinical recovery, effective 14 examples, effective 15 examples, total effective rate reaches 96.2%, it was shown that this invention treatment by Chinese herbs thyroid carcinoma effect is notable, has reached clinical treatment purpose, and over the course for the treatment of, have no obvious adverse reaction.
In order to more detailed description treats situation, the curative effect situation of model case given below and treatment:
Case 1:
What certain, female, 32 years old, thyroid papillary carcinoma engendered that fullness and distention in the chest and hypochondrium is uncomfortable for postoperative 1 week, and in throat, foreign body sensation is obvious, can not swallow, not out, feels depressed, anorexia, operation on neck tract pain, and cicatrix is obvious, white and thin fur, stringy pulse. After taking 1 course for the treatment of of this Chinese medicine, patient's above-mentioned symptom alleviates gradually.After continuing to take 3 courses for the treatment of of this Chinese medicine, symptom and sign disappears substantially.
Case 2:
Wei, female, 28 years old, papillary thyroid carcinoma was postoperative, and the clear first of radioiodine engenders spirit depressing after treating 3 days, irritability is easily cried, and coerces rib distension, breathes hard, and swallowing chokes with sobs has some setbacks, and coughs and tells a small amount of viscous expectorant, operation on neck tract pain sense of discomfort is obvious, change one's position, come back limited, greasy fur, rolling pulse. After taking 1 course for the treatment of of this Chinese medicine, patient's above-mentioned symptom improves gradually. Following the service is with after 3 courses for the treatment of of this Chinese medicine, and symptom substantially alleviates.
Case 3:
Tall certain, female, 38 years old, the postoperative first quarter moon of thyroid papillary carcinoma engendered that operative site numbness is stiff, and throat is sticky not well, when swallowing, foreign body sensation is obvious, can not swallow, not out, feels depressed, and irritability is easily cried, chest is full vexed, the vexed belch of gastral cavity, anorexia, greasy and thin fur, stringy pulse. After taking 1 course for the treatment of of this Chinese medicine, patient's above-mentioned symptom improves gradually. Following the service is with after 3 courses for the treatment of of this Chinese medicine, and symptom substantially alleviates.
Case 4:
Wu, man, 45 years old, thyroid papillary carcinoma engendered spirit depressing in postoperative 1 week, wordless, depressed, feels depressed, irritability, fullness and distention in the chest and hypochondrium, and swallowing chokes with sobs has some setbacks, and belch frequency is made, and involves pain, greasy and thin fur, stringy pulse during cervical region activity. After taking 2 courses for the treatment of of this Chinese medicine, patient's above-mentioned symptom improves gradually. Following the service is with after 2 courses for the treatment of of this Chinese medicine, and symptom and sign is obviously improved.
Case 5:
Luo, man, 38 years old, thyroid papillary carcinoma, row thyroid cuts the+clear first treatment of Neck Dissection+radioiodine entirely, engenders cervical region numbness, pain occur after treatment between January, involving pain, xerostomia during cervical region activity, dry pharynx blocks if any thing, swallowing chokes with sobs has some setbacks, and distending pain in the chest and hypochondrium feels depressed, and pressure is very big, happiness is sighed, lack of appetite poor appetite, greasy and thin fur, stringy pulse. After taking 2 courses for the treatment of of this Chinese medicine, patient's above-mentioned symptom improves gradually. Following the service is with after 2 courses for the treatment of of this Chinese medicine, and symptom and sign disappears substantially.
(6), conclusion
Being shown by above-mentioned situation, the present invention is the active drug for improving thyroid carcinoma postsurgery symptoms (syndrome of qi stagnation and blood stasis), and effective percentage reaches more than 96.2%, has no side effect, and stable curative effect is safe and reliable, and clinical meaning is huge.
Claims (4)
1. the Chinese medicine compound improving thyroid carcinoma postsurgery symptoms (syndrome of qi stagnation and blood stasis), it is characterized in that, this compound recipe is by weighing scale: Radix Bupleuri 8-15g, Pericarpium Citri Reticulatae Viride 10-20g, Rhizoma Chuanxiong 15-25g, Rhizoma Cyperi 15-25g, Spica Prunellae 20-30g, Radix Curcumae 15-25g, Bulbus Fritillariae Uninbracteatae 10-20g, Radix Ranunculi Ternati 20-30g, Rhizoma Dioscoreae Nipponicae 15-25g, Herba Hedyotidis Diffusae 20-30g, Pseudobulbus Cremastrae Seu Pleiones 20-30g, Nidus Vespae 20-30g, Rhizoma Sparganii 10-20g, Rhizoma Curcumae 10-20g, winged euonymus 20-30g, Herba Salviae Chinensis 20-30g, Radix Rhapontici 15-25g, Concha Arcae 15-25g, CATHARSIUS 20-30g, Scorpio 10-15g, Scolopendra 10-15g, Pheretima 10-15g, Bombyx Batryticatus 10-15g, Squama Manis 8-15g, Carapax Trionycis 10-20g makes, wherein, above-mentioned Chinese medicine is mixed, put in container, add 1000ml water soaking half an hour, intense fire decocts to boiling, use slow fire boiling instead 30 minutes, filter, obtain filtrate, filtering residue adds 800ml water and decocts once again, filter, obtain filtrate, twice filtrate mixing is concentrated into 200-300ml, obtain.
2. one according to claim 1 improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (syndrome of qi stagnation and blood stasis), it is characterized in that, this compound recipe is by weighing scale: Radix Bupleuri 8g, Pericarpium Citri Reticulatae Viride 10g, Rhizoma Chuanxiong 15g, Rhizoma Cyperi 15g, Spica Prunellae 20g, Radix Curcumae 15g, Bulbus Fritillariae Uninbracteatae 10g, Radix Ranunculi Ternati 20g, Rhizoma Dioscoreae Nipponicae 15g, Herba Hedyotidis Diffusae 20g, Pseudobulbus Cremastrae Seu Pleiones 20g, Nidus Vespae 20g, Rhizoma Sparganii 10g, Rhizoma Curcumae 10g, winged euonymus 20g, Herba Salviae Chinensis 20g, Radix Rhapontici 15g, Concha Arcae 15g, CATHARSIUS 20g, Scorpio 10g, Scolopendra 10g, Pheretima 10g, Bombyx Batryticatus 10g, Squama Manis 8g, Carapax Trionycis 10g makes.
3. one according to claim 1 improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (syndrome of qi stagnation and blood stasis), it is characterized in that, this compound recipe is by weighing scale: Radix Bupleuri 10g, Pericarpium Citri Reticulatae Viride 15g, Rhizoma Chuanxiong 20g, Rhizoma Cyperi 20g, Spica Prunellae 25g, Radix Curcumae 20g, Bulbus Fritillariae Uninbracteatae 15g, Radix Ranunculi Ternati 25g, Rhizoma Dioscoreae Nipponicae 20g, Herba Hedyotidis Diffusae 25g, Pseudobulbus Cremastrae Seu Pleiones 25g, Nidus Vespae 25g, Rhizoma Sparganii 15g, Rhizoma Curcumae 15g, winged euonymus 25g, Herba Salviae Chinensis 25g, Radix Rhapontici 20g, Concha Arcae 20g, CATHARSIUS 25g, Scorpio 12g, Scolopendra 12g, Pheretima 12g, Bombyx Batryticatus 12g, Squama Manis 10g, Carapax Trionycis 15g makes.
4. one according to claim 1 improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (syndrome of qi stagnation and blood stasis), it is characterized in that, this compound recipe is by weighing scale: Radix Bupleuri 15g, Pericarpium Citri Reticulatae Viride 20g, Rhizoma Chuanxiong 25g, Rhizoma Cyperi 25g, Spica Prunellae 30g, Radix Curcumae 25g, Bulbus Fritillariae Uninbracteatae 20g, Radix Ranunculi Ternati 30g, Rhizoma Dioscoreae Nipponicae 25g, Herba Hedyotidis Diffusae 30g, Pseudobulbus Cremastrae Seu Pleiones 30g, Nidus Vespae 30g, Rhizoma Sparganii 20g, Rhizoma Curcumae 20g, winged euonymus 30g, Herba Salviae Chinensis 30g, Radix Rhapontici 25g, Concha Arcae 25g, CATHARSIUS 30g, Scorpio 15g, Scolopendra 15g, Pheretima 15g, Bombyx Batryticatus 15g, Squama Manis 15g, Carapax Trionycis 20g makes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610181052.2A CN105664063A (en) | 2016-03-28 | 2016-03-28 | Traditional Chinese medicine compound for improving thyroid carcinoma postoperative symptoms (syndrome of Qi stagnation and blood stasis) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610181052.2A CN105664063A (en) | 2016-03-28 | 2016-03-28 | Traditional Chinese medicine compound for improving thyroid carcinoma postoperative symptoms (syndrome of Qi stagnation and blood stasis) |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105664063A true CN105664063A (en) | 2016-06-15 |
Family
ID=56224085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610181052.2A Pending CN105664063A (en) | 2016-03-28 | 2016-03-28 | Traditional Chinese medicine compound for improving thyroid carcinoma postoperative symptoms (syndrome of Qi stagnation and blood stasis) |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105664063A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108743882A (en) * | 2018-08-29 | 2018-11-06 | 河南中医药大学 | A kind of Chinese medicine improving thyroid cancer postoperative pulmonary metastasis symptom |
CN108815472A (en) * | 2018-08-29 | 2018-11-16 | 河南中医药大学 | A kind of Chinese medicine improving thyroid cancer patients post-operative depression state |
CN108815470A (en) * | 2018-08-29 | 2018-11-16 | 河南中医药大学 | A kind of postoperative cracked Chinese medicine of improvement thyroid cancer |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103705862A (en) * | 2014-01-06 | 2014-04-09 | 河南中医学院 | Traditional Chinese medicine for relieving symptoms of qi depression and phlegm obstruction after thyroid cancer surgery |
CN104491676A (en) * | 2014-11-26 | 2015-04-08 | 孙长侠 | Goiter-treating stasis-removing soup |
CN104958707A (en) * | 2015-07-22 | 2015-10-07 | 张喜友 | Formula and production process of thyroid panacea |
-
2016
- 2016-03-28 CN CN201610181052.2A patent/CN105664063A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103705862A (en) * | 2014-01-06 | 2014-04-09 | 河南中医学院 | Traditional Chinese medicine for relieving symptoms of qi depression and phlegm obstruction after thyroid cancer surgery |
CN104491676A (en) * | 2014-11-26 | 2015-04-08 | 孙长侠 | Goiter-treating stasis-removing soup |
CN104958707A (en) * | 2015-07-22 | 2015-10-07 | 张喜友 | Formula and production process of thyroid panacea |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108743882A (en) * | 2018-08-29 | 2018-11-06 | 河南中医药大学 | A kind of Chinese medicine improving thyroid cancer postoperative pulmonary metastasis symptom |
CN108815472A (en) * | 2018-08-29 | 2018-11-16 | 河南中医药大学 | A kind of Chinese medicine improving thyroid cancer patients post-operative depression state |
CN108815470A (en) * | 2018-08-29 | 2018-11-16 | 河南中医药大学 | A kind of postoperative cracked Chinese medicine of improvement thyroid cancer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103705862B (en) | A kind of Chinese medicine improving the postoperative stagnation of QI stagnation of phlegm card of thyroid carcinoma | |
CN103705861B (en) | A kind of Chinese medicine improving the postoperative deficiency of qi and blood card of thyroid carcinoma | |
CN103656539B (en) | A kind of Chinese medicine improving excessive liver fire syndrome after thyroid carcinoma surgery | |
CN103705863B (en) | A kind of Chinese medicine improving the postoperative syndrome of deficiency of both qi and yin of thyroid carcinoma | |
CN103690763B (en) | A kind of Chinese medicine improving the postoperative wind heat of thyroid carcinoma and violate exterior syndrome | |
CN102406902B (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN105664063A (en) | Traditional Chinese medicine compound for improving thyroid carcinoma postoperative symptoms (syndrome of Qi stagnation and blood stasis) | |
CN103690924B (en) | A kind of Chinese medicine improving the postoperative deficiency syndrome of both YIN and YANG of thyroid carcinoma | |
CN101104031B (en) | Internal-applied traditional Chinese medicine composition for treating nasopharyngeal cancer | |
CN104257977A (en) | Traditional Chinese medicine preparation for treating liver-stomach disharmony type chronic superficial gastritis | |
CN104547736A (en) | Medicine for treating goiter | |
CN103816352B (en) | One treats colpitic Chinese medicine preparation and preparation method | |
CN103405729B (en) | Traditional Chinese medicine for treating stationary thyroid-associated ophthalmopathy | |
CN102389464A (en) | Traditional Chinese medicine used for treating acute mastitis | |
CN105434739A (en) | Traditional Chinese medicine composition for treating chalazia and preparation method thereof | |
CN105327171A (en) | Traditional Chinese medicine electuary for treating mastitis and preparing method thereof | |
CN104162111A (en) | Oral traditional Chinese medicine for treating hemangiomas | |
CN103893432A (en) | Pharmaceutical composition for treating fracture and soft tissue injury and preparation method of pharmaceutical composition | |
CN104666765A (en) | Traditional Chinese medicine formula for treating thyroid cancer and preparation method of instant granule of traditional Chinese medicine formula | |
CN104524312B (en) | A kind of Chinese medicine composition and preparation method for the treatment of expectorant knot blood stasis type thyroid adenoma | |
CN106266107A (en) | A kind of Chinese medicine composition treating sucutaneous nodule goiter and preparation method thereof | |
CN106256371A (en) | A kind of Chinese medicine composition treating blood stasis type abdominal mass and preparation method thereof | |
CN105232661A (en) | Traditional Chinese medicine composition for treating mastitis and preparation method thereof | |
CN104383355A (en) | Chinese herba preparation for treating chronic hypertrophic rhinitis | |
CN105362851A (en) | Method for preparing traditional Chinese medicine composition for treating hyperplasia of mammary glands |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160615 |
|
WD01 | Invention patent application deemed withdrawn after publication |